Dr Querfeld on Durvalumab Plus Lenalidomide vs Durvalumab in Advanced Cutaneous T-Cell Lymphoma | OncLive
Dr Querfeld on Durvalumab Plus Lenalidomide vs Durvalumab in A…
8 months ago
onclive.com
Highlights of Durvalumab for Advanced Bladder Cancer | OncLive
Highlights of Durvalumab for Advanced Bladder Cancer | OncLive
1 week ago
onclive.com
FDA Approval of Durvalumab for Advanced Bladder Cancer
FDA Approval of Durvalumab for Advanced Bladder Cancer
Apr 22, 2017
onclive.com
Durvalumab in Stage III NSCLC Based on Performance Status | OncLive
Durvalumab in Stage III NSCLC Based on Performance Status | On…
Jul 13, 2020
onclive.com
How Durvalumab Has Changed the Standard of Care | OncLive
How Durvalumab Has Changed the Standard of Care | OncLive
2 weeks ago
onclive.com
7.6K views · 52 reactions | In patients with muscle-invasive bladder cancer, recurrences after standard treatment are common. Adding perioperative durvalumab to standard treatment may improve outcomes. Research findings are summarized in a new Quick Take video. Full research findings in comments. | The New England Journal of Medicine | Facebook
2:30
7.6K views · 52 reactions | In patients with muscle-invasive blad…
1.7K views2 weeks ago
FacebookThe New England Journal of Medicine
Dr. Gulley Discusses a Phase II Study of Olaparib and Durvalumab in mCRPC
Dr. Gulley Discusses a Phase II Study of Olaparib and Durvaluma…
Feb 10, 2018
onclive.com
NSCLC Care: Evaluating Durvalumab in the First-Line Setting
Dec 28, 2023
reachmd.com
Dr. Sonpavde on Fixed-Dose Durvalumab and Tremelimumab S…
Feb 10, 2018
onclive.com
6:06
PACIFIC Trial: Durvalumab Following Chemotherapy for Stag…
2.9K viewsJul 13, 2020
YouTubeOncLive
Stage III NSCLC: When to Start Durvalumab
1.3K viewsJun 26, 2020
YouTubeOncLive
12:30
Importance of Safety Monitoring of Medicine || Part1, L-2, Unit-1 || Pha…
21.8K viewsMar 25, 2023
YouTubeGraceful Pharma
10:02
Tumore del polmone localmente avanzato, con durvalumab soprav…
7.8K viewsJun 9, 2021
YouTubePharmaStarTV
6:47
Durvalumab improves PFS in stage III lung cancer
2.5K viewsSep 9, 2017
YouTubeVJOncology
No new advances in systemic treatments for limited-stage small …
1.7K views11 months ago
FacebookThe New England Journal of Medicine
2:02
Mechanism of action of daratumumab
5.3K viewsMay 9, 2016
YouTubeVJHemOnc – Video Journal of Hematology & H…
15:07
Most important questions of Pharmacotherapeutic || D Pharm2…
60.5K viewsJan 26, 2023
YouTubeEazy pharma
Consolidation Durvalumab Could Be New SOC in Limited-Stage SCLC
1.1K viewsJun 2, 2024
YouTubeASCOcancer
Treating for Stage III NSCLC After Progression on Durvalumab | Onc…
Jul 13, 2020
onclive.com
Chapter-14 Pharmacotherapy of Alzheimer Disease - Pharmacother…
Dec 25, 2022
YouTubeKcl Tutorials
1:30
Oral Route of Drug Administration - Pharmacology
9.4K viewsSep 17, 2019
YouTubeIndian Medico
4:55
HIMALAYA: tremelimumab + durvalumab in unresectable HCC
1.2K viewsJan 31, 2022
YouTubeVJOncology
57:16
Pharmacology-I BSN 3rd semester Unit-2 Drug's used to treat infectio…
11.2K viewsFeb 14, 2022
YouTubeLecture's by Mushrifa Azhar KMU
20:24
Immuno pharmacology || Immunostimulant || Immonosuppr…
30.5K viewsJun 17, 2024
YouTubeDEPTH OF BIOLOGY
3:49
Preparing for Immunotherapy
NATIONALLY RATED HOSPITAL
About this channel
YouTubeFox Chase Cancer Center
2:12
Cancer immunotherapy | The PD-L1 pathway
212.3K viewsMay 26, 2016
YouTubeRoche
1:16
Explaining Immunotherapy, PD-L1 and PD-1
38.6K viewsSep 14, 2020
YouTubeAmerican Lung Association
8:42
IMMUNOTHERAPY: The Path to a Cancer Cure (For Clinicians)
774.1K viewsJun 4, 2017
YouTubeSociety for Immunotherapy of Cancer
13:46
Understanding Follicular Lymphoma with Sarah Rutherford, MD
31K viewsApr 23, 2020
YouTubeLymphoma Research Foundation
1:20
How does PD-L1 impact treatment options for lung cancer?
14K viewsSep 14, 2020
YouTubeAmerican Lung Association
See more videos
Static thumbnail place holder